Corteva, Inc. Q2 FY26 Results — Earnings Call Analysis

Published 29 May 2026 | Chemicals | Market Cap: ₹53.9K Cr

- Next-gen aboveground products launching in North America by 2030; Latin America will have both above and below ground products by 2030-2031. - Full year 2026 guidance reaffirmed: - Operating EBITDA expected between $4.0B to $4.2B - Operating EBITDA margin forecasted at 22% to 23% - Operating EPS projected in the range of $3.45

From Corteva, Inc.'s Q2 FY26 earnings-call transcript · updated 29 May 2026.

Price

80.6

Market Cap

₹53.9K Cr

P/E Ratio

42.8

Revenue Rank

Rank 3

Margin Rank

Rank 3

How does Corteva, Inc. rank in Chemicals?

Compare Corteva, Inc. against every Chemicals company this quarter on revenue, margins and earnings-call signals.

Revenue: Rank 3Margin: Rank 3
View Chemicals leaderboard →

📊 Revenue & Sales Performance

Rank 3
  • Next-gen aboveground products launching in North America by 2030; Latin America will have both above and below ground products by 2030-2031.
  • Pipeline includes at least 7 new active ingredients expected over the next decade.
  • New products projected to push $2 billion in revenue this year, with growth continuing.
  • Key future blockbusters include Avisa in Latin America, plus upcoming biologicals enhancing farm gate value.
  • Crop Protection volume growth expected mainly from Latin America in the second half of the year, driven by more acres planted and expanding biological portfolio.
  • Seed volumes up 6% in Q1 with strong early-season deliveries; price mix improving low to mid-single digits in second half.
  • Crop Protection volumes up 6% with new products and spinosyn driving double-digit growth.
  • Biofuel crop program expanding acreage significantly next few years, supporting long-term growth.
  • Overall, moderate organic growth expected with Crop Protection industry projected to grow low single digits in 2026.

📈 Profitability & Margins

Rank 3
  • Full year 2026 guidance reaffirmed:
  • - Operating EBITDA expected between $4.0B to $4.2B
  • - Operating EBITDA margin forecasted at 22% to 23%
  • - Operating EPS projected in the range of $3.45 to $3.70, representing ~7% growth at midpoint
  • Strong Q1 2026 performance with 21% increase in EBITDA and 240 basis points margin expansion
  • Continued organic growth supported by price mix, volume gains, and cost savings
  • Expect modest industry growth in crop protection low single digits in 2026 with positive signs into 2027
  • New products pipeline expected to drive growth, including 7 new active ingredients and biologicals in crop protection
  • Seed business becoming royalty positive this year, supported by $1B+ incremental revenue from out-licensing and hybrid wheat program
  • Productivity initiatives and cost discipline contributing to margin expansion and free cash flow conversion in line with midterm targets

🏗️ Capital Expenditure Plans

Yes
  • Expansion of biofuel crop development program globally with multiple partners.
  • Growing sustainable aviation fuel crop acreage: ~100,000 acres harvested in the southern U.S. last fall, expanding to over 400,000 acres next year.
  • Launching 50-50 JV with BP in Latin America to expand mustard crops, and starting canola and sunflower, with material planting expected in 2027.
  • Investment in proprietary next-gen aboveground and belowground traits for Vylor (formerly Corteva Seed & Genetics), expected around 2030-2031.
  • Continuing development and commercialization of at least 7 new active ingredients and biological products in Crop Protection over the next decade.
  • $1.5 billion discretionary contribution to U.S. pension plan supporting capital structure setup for both standalone companies post spin-off.
  • Strategic spend related to separation and setting up management and operational structures for new entities, including filing Form 10 and public listing preparations.

💰 Fundraising & Capital Structure

No information
  • No explicit mention of new fundraising through debt or equity in the provided transcript.
  • The company aims for both new businesses post-separation to maintain investment-grade credit profiles.
  • Board approved a $1.5 billion discretionary contribution to the U.S. pension plan to help position both companies for long-term success; this was funded from existing resources.
  • Capital structures for the two separated companies are being finalized, targeting investment-grade leverage levels.
  • No specific plans announced for issuing new debt or equity; focus is on strong balance sheets and credit metrics.
  • Share repurchase plan remains in place with approximately $500 million planned in the first half of the year.
  • Overall, current strategy emphasizes prudent capital allocation rather than raising new funds.

📋 Order Book & Pipeline

Yes
  • The order book currently reflects expectations of increased corn acreage in the U.S., indicating strong demand (Page 8).
  • Latin America is a key driver for second-half volume growth, with more acres planted and growing demand for biologicals such as Nutricia and Blue (Page 11).
  • Crop Protection volumes forecast to grow from single digits in the first half to high single digits in the second half, primarily driven by Latin America (Page 11).
  • Strong demand exists for corn and soybean technology, supported by Bayer agreement, contributing about $1 billion in royalty revenue growth over the next decade (Page 5).
  • Biologicals and new product launches expected to contribute meaningfully to order growth in the second half, especially in Latin America (Page 4).

Key Metrics

Revenue

Rank 3

Margin

Rank 3

Capex

Yes

Fundraise

No information

Order Book

Yes

Others in Chemicals this season

  • Westlake Corporation (Q2 FY26)

    Westlake Corporation Q2 FY26 quarterly results analysis. HIP segment volume growth driven by strong infrastructure spending and data center cooling needs, suppo

  • RPM International Inc. (Q2 FY26)

    RPM International Inc. Q2 FY26 quarterly results analysis. RPM expects mid-single-digit revenue growth in Q4 fiscal ’26, aided by M&A (Page 4). Market Cap $13,6

  • Solstice Advanced Materials, Inc. (Q2 FY26)

    Solstice Advanced Materials, Inc. Q2 FY26 quarterly results analysis. Strong momentum heading into Q2 with 5 planned maintenance outages on track (Page 9). Mark

  • International Flavors & Fragrances Inc. (Q2 FY26)

    International Flavors & Fragrances Inc. Q2 FY26 quarterly results analysis. The company expects solid top-line growth driven by volume growth across all segment

Frequently Asked Questions

What were Corteva, Inc. Q2 FY26 results?

- Next-gen aboveground products launching in North America by 2030; Latin America will have both above and below ground products by 2030-2031. - Full year 2026 guidance reaffirmed: - Operating EBITDA expected between $4.0B to $4.2B - Operating EBITDA margin forecasted at 22% to 23% - Operating EPS projected in the range of $3.45

What is Corteva, Inc. share price analysis?

Corteva, Inc. currently shows a below-average growth signal. The stock trades at a P/E of 42.8 with a market cap of $53,907. Investors should review the full earnings analysis for detailed insights.

Is Corteva, Inc. planning capital expenditure?

- Expansion of biofuel crop development program globally with multiple partners. - Growing sustainable aviation fuel crop acreage: ~100,000 acres harvested in the southern U.S.

Keep Corteva, Inc. on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.